insights_auto
Why is DMYD-B down 4.80%?
Dive Deeperchevron_right
DMYD-B:STO
Diamyd Medical AB
SEKÂ 0.89
arrow_downward
-4.80%(-0.045) 1D
Nov 20, 5:29:38 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMYD-B...
Open
SEKÂ 0.92
High
SEKÂ 0.94
Low
SEKÂ 0.89
Mkt. cap
135.12M
Avg. vol.
501.53K
Volume
475.60K
52-wk high
SEKÂ 17.88
52-wk low
SEKÂ 0.86
EPS
-SEKÂ 1.76
Shares outstanding
134.00M
No. of employees
42
Open
SEKÂ 0.92
High
SEKÂ 0.94
Low
SEKÂ 0.89
Mkt. cap
135.12M
Avg. vol.
501.53K
Volume
475.60K
52-wk high
SEKÂ 17.88
52-wk low
SEKÂ 0.86
EPS
-SEKÂ 1.76
Shares outstanding
134.00M
No. of employees
42
News stories
From web sources and news partners
Nacionale
·
5 hours ago
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Yahoo Finance
·
2 hours ago
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Beinsure
·
8 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employees42
Founded1984
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitediamyd.com